- Blistering skin disease
- Bullous dermatitis
- Bullous pemphigoid
- Cicatricial pemphigoid
- Epidermolysis bullosa
- Epidermolysis bullosa acquisita (EBA)
- Hailey-Hailey disease
- Linear igA bullous dermatosis
- Linear igA bullous disease
- Mucous membrane pemphigoid
- Paraneoplastic pemphigus (PNP)
- Pemphigus foliaceus
- Pemphigus vulgaris
Christoph Thomas Ellebrecht, MD
About me
- Assistant Professor of Dermatology
My education and training
- Medical School: Universitate Luebeck
- Residency: University Hospital Schleswig-Holstein
- Residency: Temple University Hospital
- Residency: University of Pennsylvania Health System
Spoken languages
Reviews
361 reviews
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Insurance accepted
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Americhealth Caritas of PA VIP - LGH Only
- Amerihealth Caritas (Transplant patients only)
- Amerihealth Caritas of PA - LGH Only
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
- Pennsylvania Hospital: Has privileges to treat patients in the hospital.
- Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Qualifications and experience
- Dermatology
- Alumni German National Academic Foundation, National
- American Association of Dermatology, National
- American Association of Immunologists, National
- American Society for Gene and Cell Therapy, International
- European Society for Dermatological Research, International
- Gesellschaft der Freunde und Förderer der Universität zu Lübeck, National
- Israel Science Foundation, International
- NIH, National
- NIH, National
- Penn Institute for mRNA Innovation, Local
- Penn Skin Biology and Diseases Resource-based Center, Local
- Society for Immunotherapy of Cancer, National
- Society for Investigative Dermatology, National
Treatments and conditions
Research
Publications
Caitlin S. Frazee, Sisi Chen, Corbett T. Berry, Casey S. Lee, Reid A. Banciella, Lucianna Ngo, David Shon, Patrick J. Herman, Jake S. Fischman, Chloe L. Leff, Anna Chen, Yvonne Kuo, Alexander A. Shestov, Andre R. Kelly, Bakir Valentic, Michael C. Milone, Roddy S. O'Connor, Christoph T. Ellebrecht Fate induction through asymmetric T cell division is modulated by chimeric antigen receptor co-stimulatory domains , Nature Immunology : 2026
Corbett T. Berry, Caitlin S. Frazee, Patrick J. Herman, Sisi Chen, Anna Chen, Yvonne Kuo, Christoph T. Ellebrecht Current advancements in cellular immunotherapy for autoimmune disease , Semin Immunopathol., 47(7): 2025
Christoph Ellebrecht, Aimee Payne Pemphigus , Fitzpatrick's Dermatology 10th edition: 2025
Lee CS, Chen S, Berry CT, Kelly AR, Herman PJ, Oh S, O'Connor RS, Payne AS, Ellebrecht CT Fate induction in CD8 CAR T cells through asymmetric cell division , Nature, 633: 2024,670–677
Corbett Berry, Casey Lee, Sisi Chen, Caitlin Frazee, Patrick Herman, Anna Chen, Andre Kelly, Roderick O'Connor, Christoph Ellebrecht Asymmetric epigenetic and metabolic remodeling of engineered CD4 T cells drives divergent cell fate , Society of Investigative Dermatology: 2024
Chat, Vipawee S., Ellebrecht, Christoph T., Kingston, Paige, Gondo, George, Bell, Stacie, Cordoro, Kelly M., Desai, Seemal R., Duffin, Kristina C., Feldman, Steven R., Garg, Amit, Gelfand, Joel M., Gladman, Dafna, Green, Lawrence J., Gudjonsson, Johann, Han, George, Hawkes, Jason E., Kircik, Leon, Koo, John, Langley, Richard, Lebwohl, Mark, Michael Lewitt, G., Liao, Wilson, Martin, George, Orbai, Ana-Maria, Reddy, Soumya M., Richardson, Veronica, Ritchlin, Christopher T., Schwartzman, Sergio, Siegel, Evan L., Van Voorhees, Abby S., Wallace, Elizabeth B., Weinberg, Jeffrey M., Winthrop, Kevin L., Yamauchi, Paul, Armstrong, April W. Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis Foundation , Journal of the American Academy of Dermatology, 90((6):1170-1181.): 2024,1170-1181
Oh S, Mao X, Manfredo-Vieira S, Lee J, Patel D, Choi EJ, Alvarado A, Cottman-Thomas E, Maseda D, Tsao PY, Ellebrecht CT, Khella SL, Richman DP, O'Connor KC, Herzberg U, Binder GK, Milone MC, Basu S, Payne AS. Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells. , Nat Biotechnol. , 42(12): 2023,1923
Christoph T. Ellebrecht, Aimee S. Payne Fitzpatrick's Therapeutics: A Clinician's Guide to Dermatologic Treatment , Fitzpatrick's Therapeutics: A Clinician's Guide to Dermatologic Treatment, 1st Edition, McGraw Hill: 2023
Wat M, Mollanazar NK, Ellebrecht CT, Forrestel A, Elenitsas R, Chu EY. Lichen-planus-pemphigoides-like reaction to PD-1 checkpoint blockade. , J Cutan Pathol. , 49(11): 2022,978-987
Ellebrecht CT, Maseda D, Payne AS. Pemphigus and Pemphigoid: From Disease Mechanisms to Druggable Pathways. , J Invest Dermatol. , 142(3): 2022,907-914